ATP1A2

Chr 1ADAR

ATPase Na+/K+ transporting subunit alpha 2

Also known as: DEE98, FARIMPD, FHM2, MHP2

The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008]

Primary Disease Associations & Inheritance

Alternating hemiplegia of childhood 1MIM #104290
AD
Developmental and epileptic encephalopathy 98MIM #619605
AD
Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic faciesMIM #619602
AR
Migraine, familial basilarMIM #602481
AD
Migraine, familial hemiplegic, 2MIM #602481
AD
596
ClinVar variants
50
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryATP1A2
🧬
Gene-Disease Validity (ClinGen)
hemiplegic migraine-developmental and epileptic encephalopathy spectrum · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.33) despite low pLI — interpret in context.
📋
ClinVar Variants
50 Pathogenic / Likely Pathogenic· 287 VUS of 596 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.49LOEUF
pLI 0.000
Z-score 4.37
OE 0.33 (0.220.49)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
4.77Z-score
OE missense 0.45 (0.410.50)
274 obs / 604.0 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.33 (0.220.49)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.45 (0.410.50)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.99
01.21.6
LoF obs/exp: 16 / 49.1Missense obs/exp: 274 / 604.0Syn Z: 0.07

ClinVar Variant Classifications

596 submitted variants in ClinVar

Classification Summary

Pathogenic19
Likely Pathogenic31
VUS287
Likely Benign180
Benign56
Conflicting23
19
Pathogenic
31
Likely Pathogenic
287
VUS
180
Likely Benign
56
Benign
23
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
5
5
0
19
Likely Pathogenic
10
20
1
0
31
VUS
4
224
53
6
287
Likely Benign
0
4
75
101
180
Benign
0
0
56
0
56
Conflicting
23
Total23253190107596

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ATP1A2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

ATP1A2-related epileptic encephalopathy

moderate
ADGain Of FunctionAltered Gene Product Structure
Dev. Disorders
G2P ↗
splice region variantmissense variant

ATP1A2-related neuronal migration disorder with epilepsy

strong
ARUndeterminedAbsent Gene Product
Dev. Disorders
G2P ↗
stop gained NMD triggeringframeshift variant NMD triggering

ATP1A2-related migraine, familial hemiplegic

definitive
ADLoss Of FunctionAbsent Gene Product
Dev. Disorders
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Alternating hemiplegia of childhood 1

MIM #104290

Molecular basis of disorder known

Autosomal dominant

Developmental and epileptic encephalopathy 98

MIM #619605

Molecular basis of disorder known

Autosomal dominant

Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies

MIM #619602

Molecular basis of disorder known

Autosomal recessive

Migraine, familial basilar

MIM #602481

Molecular basis of disorder known

Autosomal dominant

Migraine, familial hemiplegic, 2

MIM #602481

Molecular basis of disorder known

Autosomal dominant
📖
GeneReview available — ATP1A2
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Diagnostic and therapeutic aspects of hemiplegic migraine.
Di Stefano V et al.·J Neurol Neurosurg Psychiatry
2020Review
Hemiplegic migraine.
de Boer I et al.·Handb Clin Neurol
2024Review
Familial hemiplegic migraine.
Villar-Martinez MD et al.·Handb Clin Neurol
2024Review
Pathophysiology of migraine aura.
Sanchez Del Rio M et al.·Handb Clin Neurol
2023Review
Migraine: Genetic Variants and Clinical Phenotypes.
Rainero I et al.·Curr Med Chem
2019Review
Advances in genetics of migraine.
Sutherland HG et al.·J Headache Pain
2019Review
Migraine - a borderland disease to epilepsy: near it but not of it.
Paungarttner J et al.·J Headache Pain
2024Review
Genetics of headaches.
Van Den Maagdenberg AM et al.·Handb Clin Neurol
2010
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →